BackCorMedix Overview
CorMedix Inc

CorMedix Target Price

Analysts' average 12-month price target for CorMedix is $15.

Get informed when a big investor buys or sells

+ Follow

Share Price

$7.19

Average Target Price

$15.00108.6% upside

1 analysts in the last 4 months

High: $15 | Low: $15

Analyst Recommendations

No recommendations in the last 4 months.

Revenue & Income Forecast

Analysts' Target Prices

DateAnalystPrice TargetCurrent Upside/Downside
2026-09-23OppenheimerLes Sulewski$15108.6% upsideOpen
2026-04-28RBC CapitalLeonid Timashev$1494.7% upsideOpen
2026-03-06Leerink PartnersRoanna Ruiz$1380.8% upsideOpen
2026-01-23H.C. Wainwright$1380.8% upsideOpen
2026-01-21RBC Capital$1380.8% upsideOpen
2026-01-08Truist Financial$16122.5% upsideOpen
2025-10-21RBC CapitalGregory Renza$22206% upsideOpen
2025-08-08H.C. WainwrightBrandon Folkes$17136.4% upsideOpen
2024-03-13RBC CapitalGregory Renza$925.2% upsideOpen

CorMedix (CRMD) FAQ

CorMedix (CRMD) currently reports a target price of $15. Use the charts on this page to explore CorMedix's target price history and peer comparisons.

Analysts' average 12-month price target for CorMedix is $15, about 108.6% upside from the current share price of $7.19. That spread summarizes where covering analysts expect the stock could trade over the next year, not a guarantee. Review the individual firm targets on this page — a wide high-to-low range often means opinion is split.

Start with the current target price of $15, then check the historical chart for trend and the peer comparison chart for relative positioning. From there, open related valuation or income-statement pages for CorMedix, and consider following CRMD for alerts when major investors trade the stock.

CorMedix is classified in the Healthcare sector. On target price, it currently shows $15. Sector peers often share similar capital intensity and growth regimes, so relative rankings inside Healthcare are usually more informative than comparing CRMD with unrelated industries.